Roles
- Assistant Professor of Clinical Neurology
-
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 5 clinical trials.
-
This study aims to evaluate the safety and efficacy of ravulizumab administered in the vein in pediatric patients with Neuromyelitis Optica Spectrum Disorder (NMOSD). This study involves an investigational drug called ravulizumab, developed to treat Neuromyelitis Optica Spectrum Disorder (NMOSD). This is an ultra-rare, severe disorder of the central nervous system. Ravulizumab is considered an experimental drug, which means it is not approved for use in NMOSD in any country at this time.
- Principal Investigator: Kottil Rammohan
- Study Phase: TBD
- Enrollment Status: Open
-
Study MN43964 is a single-arm, open-label extension (OLE), rollover study of ocrelizumab that allows for participants in Parent studies WA21092, WA21093 (OPERA I and II) and WA25046 (ORATORIO) to continue treatment with ocrelizumab and thereby, aims at the continuation of collecting long-term safety and efficacy data.
- Principal Investigator: Ramon Flores Gonzalez
- Study Phase: Phase III
- Enrollment Status: Not Accepting
-
An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis
- Principal Investigator: Ramon Flores Gonzalez
- Study Phase: Phase 3
- Enrollment Status: Not Accepting
-
A Multicenter, Single Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Principal Investigator: Ramon Flores Gonzalez
- Study Phase: Phase 3
- Enrollment Status: Closed
-
An Open-Label, Prospective, Single-arm, Multi-center Study to Assess Disease Activity and Biomarkers of Neuronal Damage in Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab
- Principal Investigator: Ramon Flores Gonzalez
- Study Phase: Phase 4
- Enrollment Status: Closed